AXT Inc (NASDAQ:AXTI - Get Free Report) Director Leonard Leblanc sold 2,000 shares of the firm's stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $88.31, for a total transaction of $176,620.00. Following the completion of the sale, the director owned 117,129 shares in the company, valued at $10,343,661.99. This represents a 1.68% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

AXT Stock Performance

• 3 Under-The-Radar Small Caps Making New All-Time Highs

NASDAQ AXTI opened at $73.43 on Thursday. The firm's fifty day moving average price is $68.06 and its two-hundred day moving average price is $67.26. The stock has a market cap of $4.82 billion, a PE ratio of 3,671.50 and a beta of 1.90. AXT Inc has a fifty-two week low of $2.20 and a fifty-two week high of $143.16.

AXT (NASDAQ:AXTI - Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The semiconductor company reported $0.19 EPS for the quarter, beating analysts' consensus estimates of $0.07 by $0.12. AXT had a return on equity of 0.96% and a net margin of 3.23%.The company had revenue of $47.59 million during the quarter, compared to analysts' expectations of $34.08 million. AXT has set its Q3 2026 guidance at 0.300-0.320 EPS. As a group, sell-side analysts predict that AXT Inc will post 0.8 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

---

---

A number of institutional investors have recently modified their holdings of AXTI. Two Sigma Securities LLC acquired a new stake in AXT in the second quarter worth $212,000. GTS Securities LLC bought a new position in shares of AXT during the 2nd quarter worth about $991,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of AXT by 11.7% during the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 85,925 shares of the semiconductor company's stock worth $6,193,000 after purchasing an additional 9,032 shares in the last quarter. Wellington Management Group LLP acquired a new stake in shares of AXT in the 2nd quarter valued at about $25,911,000. Finally, Beacon Pointe Advisors LLC bought a new stake in AXT in the 2nd quarter valued at about $326,000. Institutional investors and hedge funds own 49.52% of the company's stock.

Key Headlines Impacting AXT

Here are the key news stories impacting AXT this week:

• Positive Sentiment: AXT’s record InP revenue, backlog exceeding $100 million and planned capacity expansion point to a potentially multiyear growth opportunity as AI data centers drive demand for optical components. AXT's InP Demand Is Surging: Can It Become a Long-Term Growth Driver?
• Positive Sentiment: Recent reports attributed prior strength in AXTI to tightening indium phosphide supply and new AI-related deals, supporting the view that AXT could benefit from increased optical-networking demand. Why AXT Is Up 11.6% After Indium Phosphide Supply Tightens Amid New AI Deals
• Neutral Sentiment: Tradr launched an exchange-traded fund featuring AXT and other optics and AI companies. The product could increase trading visibility and investor access, but its direct effect on AXT’s fundamentals remains uncertain. Tradr Debuts First-to-Market ETFs on Meta, AXT, Coherent & Lightwave Logic
• Negative Sentiment: AXTI has been caught in a broad selloff across optics and AI-hardware stocks as investors reassess the pace of AI spending and take profits after substantial sector gains. This risk-off backdrop is offsetting the company’s favorable InP demand outlook. Optics Stocks Drop on Anthropic News
• Negative Sentiment: Director Leonard Leblanc sold 4,000 AXTI shares for approximately $384,280 on August 17, following additional sales of 2,000 shares in August and 500 shares in June. Although he still owns more than 113,000 shares, the repeated transactions may raise a modest insider-confidence concern. Leonard Leblanc Sells 4,000 Shares of AXT Stock

Analyst Ratings Changes

Several analysts recently weighed in on AXTI shares. UBS Group set a $90.00 price objective on shares of AXT in a research note on Friday, July 31st. Northland Securities set a $125.00 price target on AXT in a research report on Wednesday, June 3rd. Weiss Ratings raised AXT from a "sell (d-)" rating to a "sell (d+)" rating in a research note on Friday, August 14th. Needham & Company LLC upgraded AXT from a "hold" rating to a "buy" rating and set a $90.00 price objective for the company in a research report on Friday, July 31st. Finally, B. Riley Financial cut their price objective on AXT from $73.00 to $52.00 and set a "neutral" rating on the stock in a research note on Tuesday, July 28th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $77.00.

Read Our Latest Stock Analysis on AXTI

AXT Company Profile

(Get Free Report)

AXT, Inc (NASDAQ: AXTI) is a global supplier of compound and single-element semiconductor substrates, offering a range of materials critical for high-performance electronic and optoelectronic devices. Founded in 1986 and headquartered in Fremont, California, AXT specializes in the development, manufacture and distribution of wafers composed of gallium arsenide (GaAs), indium phosphide (InP), gallium nitride (GaN) and other compound semiconductor materials. These substrates serve as the foundational platforms for devices used in data communications, wireless infrastructure, advanced computing, consumer electronics and photovoltaic applications.

AXT's product portfolio encompasses a variety of wafer sizes, dopant concentrations and crystal orientations, tailored to meet the precise specifications of its customers.

Read More

• Five stocks we like better than AXT
• One Platform, Every Ailment: Hinge Health's Gamble
• Bloom Energy’s AI Surge Meets a Valuation Reality Check
• Target Is Winning Shoppers Back—Can the Rally Reach $180?
• IonQ’s Space Contract Points to a New Frontier for Quantum Investors

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].